Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Niger J Clin Pract ; 24(10): 1511-1519, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34657018

RESUMEN

BACKGROUND AND AIMS: This study aimed to assess the outcomes of partial pulpotomy treatments using different biocompatible materials which were Biodentine®, mineral trioxide aggregate (MTA), and calcium hydroxide (CH) in cariously exposed pulp tissue in immature permanent molars. MATERIALS AND METHODS: Fifty-four teeth of 50 patients, which had cariously pulp exposures were randomly divided into Biodentine®, MTA, and CH groups for partial pulpotomy treatments and finally restored with stainless steel crowns at the same appointment. Clinical and radiographical success was evaluated by the absence of any clinical and radiographical signs and symptoms for 12 months. Also, Image J was used for the quantitative assessment of length developments for mesial and distal roots. P value of less than 0.05 was considered statistically significant. RESULTS: Partial pulpotomy treatments showed high overall success rate (87%). On the other hand, Biodentine and MTA showed higher success rates compared to CH without any statistical significance (P = 0.09). Besides, mesial and distal root lengths displayed a continuous and significant increase in each group at sixth month follow-up (P = 0.01; P = 0.03). CONCLUSIONS: Favorable results demonstrated that Biodentine, MTA, and CH might be recommended as suitable agents for partial pulpotomy treatment in cariously exposed immature molars with clinical diagnosis of normal pulp or reversible pulpitis.


Asunto(s)
Pulpitis , Pulpotomía , Compuestos de Aluminio , Materiales Biocompatibles , Compuestos de Calcio , Hidróxido de Calcio , Combinación de Medicamentos , Humanos , Diente Molar/diagnóstico por imagen , Diente Molar/cirugía , Óxidos , Silicatos/uso terapéutico , Resultado del Tratamiento
2.
Int J Gynecol Cancer ; 29(1): 53-59, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30640684

RESUMEN

OBJECTIVE: To identify factors that affect successful adaptation of sentinel lymph node mapping and those that lead to unintended adipose-only sentinel lymph node identification. METHODS: Surgical and pathological data were prospectively collected on patients with endometrial cancer who underwent sentinel lymph node mapping with indocyanine green with or without pelvic and/or para-aortic lymph node dissection between November 2013 and April 2017. All mapping cases were performed with the robotic system. Adipose-only specimens were defined as a sentinel lymph node without a pathologically identified lymph node after ultrastaging. RESULTS: A total of 202 patients were included: 83% had endometrioid pathology, 12% serous, 3% carcinosarcoma, and 2% clear cell, with mixed pathology noted in 2%. The bilateral sentinel lymph node detection rate was 66%, and the rate of mapping at least a unilateral sentinel lymph node was 86%. Neither the bilateral nor the unilateral sentinel lymph node mapping rate changed with increased surgeon experience. The rate of adipose-only sentinel lymph node identification was more frequent when comparing the first 10 cases (37%), cases 11 - 30 (28%), and > 30 cases (9%) (P = 0.006). Body mass index > 30 kg/m2, uterine fibroids, The International Federation of Gynecology and Obstetrics (FIGO) grade, and histology were not found to have a statistically significant impact on either sentinel lymph node identification or adipose-only sentinel lymph node identification. Adipose-only sentinel lymph nodes were more likely with increased time from cervical injection to identification of the sentinel lymph node in the right hemipelvis. The median range was 28 min (14-73) for true sentinel lymph node identification vs 33 min (23-74) for adipose-only sentinel lymph node identification (P = 0.02). CONCLUSION: Patient and surgeon factors did not impact the identification of sentinel lymph nodes over time. Adipose-only sentinel lymph nodes were more frequently identified in the initial cases and represent a potential complication to adapting sentinel lymph node biopsy without lymphadenectomy. The increase in adipose-only sentinel lymph node identification that was associated with time from cervical injection may represent delayed or disrupted uptake of indocyanine green.


Asunto(s)
Tejido Adiposo/patología , Algoritmos , Neoplasias Endometriales/patología , Verde de Indocianina , Ganglio Linfático Centinela/patología , Adenocarcinoma de Células Claras/patología , Adenocarcinoma de Células Claras/cirugía , Tejido Adiposo/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Carcinosarcoma/patología , Carcinosarcoma/cirugía , Colorantes , Cistadenocarcinoma Seroso/patología , Cistadenocarcinoma Seroso/cirugía , Neoplasias Endometriales/cirugía , Femenino , Estudios de Seguimiento , Humanos , Histerectomía , Escisión del Ganglio Linfático , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Estudios Retrospectivos , Procedimientos Quirúrgicos Robotizados , Ganglio Linfático Centinela/cirugía
4.
Cytogenet Cell Genet ; 65(1-2): 136-9, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-8404067

RESUMEN

Fifty-six chromosome 18-specific yeast artificial chromosomes (YAC) were isolated from a human monochromosomal somatic cell hybrid DNA library. Fluorescence in situ hybridization revealed that the clones were evenly distributed throughout the chromosome. The clones, with an average insert size of 250 kb, cover about 18% of the euchromatic part of chromosome 18. Of 90 STS markers tested, 17 were represented in this YAC collection. Together with our previously reported set of unique chromosome 18-specific YACs, we now have available 111 regionally mapped, essentially nonchimeric, clones that provide more than 30% coverage and form a framework for the complete physical map.


Asunto(s)
Cromosomas Artificiales de Levadura , Cromosomas Humanos Par 18 , Animales , Mapeo Cromosómico , Cricetinae , Electroforesis en Gel de Campo Pulsado , Humanos , Células Híbridas , Hibridación Fluorescente in Situ
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...